Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

NCT04218409 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Pain

Interventions

DRUG: OxyCODONE 5 mg Oral Tablet
DRUG: Oxytocin nasal spray
OTHER: Placebo Oxycodone
OTHER: Placebo oxytocin
DRUG: OxyCODONE 2.5 mg Oral Tablet

Sponsor

University of Florida

Collaborators

[object Object]